DepoMed (DEPO)
Create an Alert
5.84
-0.20 -3.31%
NASDAQ
Jun 19, 8:00PM
BATS Real time
Currency in USD
DepoMed Return on Equity:
-30.46% for March 31, 2013DepoMed Historical Return on Equity Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | -30.46% |
| Dec. 31, 2012 | -32.38% |
| Sept. 30, 2012 | -40.38% |
| June 30, 2012 | -43.97% |
| March 31, 2012 | -32.14% |
| Dec. 31, 2011 | 71.00% |
| Sept. 30, 2011 | 104.6% |
| June 30, 2011 | 155.0% |
| March 31, 2011 | 267.7% |
| Dec. 31, 2010 | 21.72% |
| Sept. 30, 2010 | -8.38% |
| June 30, 2010 | -12.24% |
| March 31, 2010 | -92.07% |
| Dec. 31, 2009 | -104.3% |
| Sept. 30, 2009 | -122.2% |
| June 30, 2009 | -116.5% |
| March 31, 2009 | -62.17% |
| Dec. 31, 2008 | -49.03% |
| Sept. 30, 2008 | 79.12% |
| June 30, 2008 | 526.5% |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Return on Equity (ROE)
Return on equity (ROE) measures the rate of return on the money invested by common stock owners and retained by the company thanks to previous profitable years. It demonstrates a company's ability to generate profits from shareholders' equity (also known as net assets or assets minus liabilities).
ROE shows how well a company uses investment funds to generate growth. Return on equity is useful for comparing the profitability of companies within a sector or industry.
Investors generally are interested in company's that have high, increasing returns on equity.
Learn More
DEPO Return on Equity Benchmarks
| Companies | |
|---|---|
| Lannett Company | 9.68% |
| SciClone Pharmaceuticals | 6.28% |
| POZEN | -25.52% |
DEPO Return on Equity Rankings
| Overall |
64th percentile 5954 of 16782 |
| Sector |
70th percentile 412 of 1410 in Healthcare |
| Industry |
70th percentile 45 of 152 in Drug Manufacturers - Specialty & Generic |
DEPO Return on Equity Range, Past 5 Years
| Minimum | -122.2% | Sep 2009 |
| Maximum | 526.5% | Jun 2008 |
| Average | 23.97% |
